Cofoe Medical Technology Co.,Ltd. (SHE:301087)
43.90
-1.50 (-3.30%)
At close: Jun 24, 2026
Cofoe Medical Technology Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Cofoe Medical Technology stock has a consensus rating of "Strong Buy" and an average price target of ¥61.92. The average 1-year stock price forecast is 41.05% higher than the current stock price, while the lowest is ¥53.84 (+22.64%) and the highest is ¥70.00 (+59.45%).
Price Target: ¥61.92 (+41.05%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Cofoe Medical Technology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Feb '26 | Mar '26 | Jun '26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 3 |
Financial Forecast
Revenue This Year
4.11B
from 3.39B
Increased by 21.46%
Revenue Next Year
4.78B
from 4.11B
Increased by 16.12%
EPS This Year
2.11
from 1.45
Increased by 45.75%
EPS Next Year
2.58
from 2.11
Increased by 21.92%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.2B | ||
| Avg | 4.1B | ||
| Low | 4.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 24.0% | ||
| Avg | 21.5% | ||
| Low | 18.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.21 | ||
| Avg | 2.11 | ||
| Low | 1.95 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 52.4% | ||
| Avg | 45.7% | ||
| Low | 34.5% |